资讯
Kamas-based Dendric Estate said it’s inching closer to the release of its sparkling cider next month as the cidery conducts bench trials — small-scale blending and sensory analysis. “For our inaugural ...
2 天
News-Medical.Net on MSNFirst-in-class antibody-drug conjugate shows high response rates in rare blood cancer trialThe first-in-class antibody-drug conjugate (ADC) pivekimab sunirine (PVEK) demonstrated promising efficacy and high response ...
Dendric Estate working on blending trials for first cider release - Park Record BNN-Spider 20th May 2025, 07:31 GMT+11 Dendric Estate working on blending trials for first cider release - Park Record ...
Population-adjusted indirect comparison (PAIC) of avelumab (AVE) and retifanlimab (RETI) in the first-line (1L) treatment of patients (pts) with metastatic Merkel cell carcinoma (mMCC). Survival ...
Abstract: In this study, we use hybrid between dendritic core and phenyl group containing Hydrolysis of Tris(2-dichloromethylsilyl-2-phenyl-1-ethenyl)methylsilane(G1P-6Cl). It will prove nanosized, ...
Blastic plasmacytoid dendric cell neoplasm (BPDCN) is a rare, aggressive blood cancer that often involves the bone marrow, skin and, sometimes, lymph ...
Notably, the exploration of dendritic cell vaccinations is a key area of glioma therapeutic research, and there is growing interest in it.Conclusion: This study conducts a bibliometric analysis of ...
Correspondence to Prof. Yukinori Okada, Department of Statistical Genetics, Osaka University School of Medicine Graduate School of Medicine, Suita, Osaka, Japan; yuki-okada{at}m.u-tokyo.ac.jp; Prof.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果